http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101494488-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-15 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2008-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101494488-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating fat metabolism-related diseases containing 2-cyclopentene-1-one oxime derivatives |
| abstract | Disclosed is a pharmaceutical composition for preventing and treating fat metabolism diseases such as obesity, dyslipidemia, diabetes and the like, which comprises a 2-cyclopenten-1-one oxime derivative represented by the formula (1). Specifically, the compound accelerates lipolysis in differentiated adipocytes (3T3-L1) and consequently reduces the body fat, and thus can be used for the prevention and treatment of fat metabolism diseases such as obesity, dyslipidemia and diabetes mellitus . In formula (1), R 1 represents a linear or branched C 1 -C 6 alkyl group, a cycloalkyl group, or a phenyl group having or without a substituent, and R 2 represents an aromatic group with or without a substituent. |
| priorityDate | 2007-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 336.